US 8338396
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
granted A61KA61K31/138A61K31/56
Quick answer
US patent 8338396 (Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology) held by TEVA WOMEN'S HEALTH, INC. expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/138, A61K31/56, A61K31/565, A61K31/567